助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   重度心力衰竭 的翻译结果: 查询用时:0.021秒
图标索引 在分类学科中查询
所有学科
心血管系统疾病
更多类别查询

图标索引 历史查询
 

重度心力衰竭
相关语句
  advanced heart failure
     A Clinical Observation of Intravenous Small Dose Urapidil Versus Nitroglycerin in the Treatment of Advanced Heart Failure
     小剂量乌拉地尔与硝酸甘油注射液治疗重度心力衰竭短期临床疗效的对比观察
短句来源
     A Clinical Observation of Intravenous Urapidil Versus Nitroglycerin in the Treatment of Advanced Heart Failure
     硝酸甘油与乌拉地尔注射液治疗重度心力衰竭的临床疗效观察
短句来源
     Methods: A total of 30 patients with advanced heart failure (NYHA class Ⅳ) were randomly assigned to open-labeled treatment with urapidil (n=15) or nitroglycerin (n=15).
     方法 :重度心力衰竭患者 30例 ,NYHA心功能均Ⅳ级。 被随机分为乌拉地尔组 15例 ,硝酸甘油组 15例。
短句来源
  “重度心力衰竭”译为未确定词的双语例句
     1,6-disphosphofructose in Treatment of Severe Heart Failure
     1,6-二磷酸果糖治疗重度心力衰竭
短句来源
     (2)QTd and QTcd were Significantly greater in the serious congestive heart failure group than the light congestive Heart Failure group (P<0.05), and QTd,QTcd were remarkably extended in the light Congestive Heart Failure group than the Control group(P<0.01).
     (2)重度心力衰竭组较轻度心力衰竭组QTd、QTcd显著延长(P<0.05),轻度心力衰竭组较正常对照组QTd、QTcd显著延长(P<0.01)。
短句来源
     Their ACE and AngⅡ expressions were increased than in the control subjects, but ACE/AngⅡ ratio was decreased in the patients with severe CHF than in the mild CHF.
     轻度心力衰竭患者心肌组织ACE和AngⅡ蛋白表达较正常人增高,中重度心力衰竭患者AngⅡ增高更为显著,但ACE/AngⅡ比值随着心力衰竭程度加重逐渐下降。
短句来源
     The rate of effectiveness was 86.95% and 60.86% in the group B and the group A, respectively. There was striking defference betwwen the group A and the group B (P<0.05).
     结果 :应用硝普钠后重度心力衰竭患者心功能明显改善 ,显效率86.95 % ,A组显效率 60 .86% ,两组差异有显著性 (P <0 .0 5 )。
短句来源
     Objective To research the clinical effect of 1,6 disphosphofrutose on severe heart failure.
     目的 探讨 1,6 二磷酸果糖 (FDP)治疗重度心力衰竭 (CHF)的临床疗效。
短句来源
更多       
  相似匹配句对
     Circulatory Assist——A Promising Therapeutics for Severe Heart Failure
     循环辅助——重度心力衰竭的外科治疗
短句来源
     Efficacy of spironolactone in the treatment of aged patients with congestive heart failure
     螺内酯对老年人重度心力衰竭的疗效
短句来源
     Inflammation and Heart Failure
     炎症和心力衰竭
短句来源
     severe: 3, which cannot be suffered.
     3重度,不能忍受。
短句来源
     4;
     重度,为4级。
短句来源
查询“重度心力衰竭”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  advanced heart failure
Towards an evidence based perspective in advanced heart failure care
      
Conclusions Plasma leptin concentrations correlate with the NYHA functional class suggesting anabolic metabolism in NYHA class II and catabolic metabolism in advanced heart failure which might be of prognostic relevance.
      
The aim of this study was to evaluate the feasibility and safety of CSD implantation in patients with advanced heart failure from cardiomyopathy of either idiopathic or ischemic origin.
      
Background: Although the concept of reducing wall tension as a treatment for advanced heart failure is convincing, clinical data from the Batista operation are conflicting.
      
However, this has not been shown in advanced heart failure, where inter- and intraventricular "resynchronization" cannot be obtained from the right side of the heart.
      
更多          


Sixty patients with rheumatic heart disease (RHD) and 71 normals were studied for red cell immune function by means of the rosette test of red cell C3b receptor and rosette test of red cell immune complex.It was found that the rosette rate of red cell C3b receptor decreased (p<0.01) and rosette rate of red cell immune complex increased (p<0.001)as compared with normals. The results showed that the pathogenesis of RHD may be closely related to the abnormality of red cell immune function. There was no apparent...

Sixty patients with rheumatic heart disease (RHD) and 71 normals were studied for red cell immune function by means of the rosette test of red cell C3b receptor and rosette test of red cell immune complex.It was found that the rosette rate of red cell C3b receptor decreased (p<0.01) and rosette rate of red cell immune complex increased (p<0.001)as compared with normals. The results showed that the pathogenesis of RHD may be closely related to the abnormality of red cell immune function. There was no apparent difference among the numbers of affected valves in the patients with RHD (p>0.05).The rosette rate of red cell immune complex in patients with moderate and severe heart failure was higher than in the normals and patients with mild heart failure (p<0.001). However there was no apparent difference in the rosette rate of red cell C3b receptor between them (p>0.05).

应用红细胞C3b(RBC-C3b)受体花环试验及红细胞免疫复合物(RBC-IC)花环试验,对60例风湿性心脏病(简称风心病)患者及71例正常人的红细胞免疫功能进行了对照研究。结果表明,风心病患者RBC-C3b受体花环率明显低于正常人(P<0.01),RBC-IC花环率明显高于正常人(P<0.001),提示风心病发病与红细胞免疫功能异常有密切关系。风心病患者RBC-C3b受体花环率及RBC-IC花环率与瓣膜损害的数量,无明显关系(P>0.05)。RBC-IC花环率在中至重度心力衰竭组明显高于心功能正常及轻度心力衰竭组(P<0.001),RBC-C3b受体花环率两组无明显差异(P>0.05)。

Aclinicalstudyonthrombolysiswithintravenousurokinasein1138casesofacutemyocardialinfarctionwasreported.Inordertoinvestigatetheefectsofdiferentdosesofurokinase:1023casesofacutemyocardialinfarctiontreatedbythrombolyticagentswithin6hoursafteronsetweredividedrandomlyintotwogroups,539casesinlowdosegroup[urokinase,UK17000(22000IU)/kg,totaldosenolowerthan900000(1170000IU)]and484casesinhighdosegroup[23000U(30000IU)/kg,totaldosenomorethan1800000U(2340000IU)].Thepatencyofinfarct-re-latedcoronaryarterywasasesedbyuniformclinicalcriteria.Thepatencyrateswere67.3%and67.8%respectively(P>0.05).Four-wekmortalitywas9.5%and8.7%respectively(P>0.05).Frequencyofvariousseverecomplicationshadnostatisticalsignificancebetwenthetwogroups.Theefectsofdiferentdosesweresimilar.Adversebleedingactionswerealitlemoreinhighdosegroupthaninlowdosegroup(P>0.05).But,2casesoffatalcerebralhemorhageoccuredinthehighdosegroup.So,thelowdoseUKwasequalyefectiveandmaybesafer.(2)Efectsofdelayedthrombolytictherapy(6-12hoursafteronsetwithurokinase[20000U(26000IU)/kg]in115casesofacutemyocardialinfarctionwerestudied.Incomparisonwiththosetreatedwithin6hoursthepa-tencyrateofinfarct-relatedarterywaslower(40.0%vs67.5%,P<0.001);four-weekmortalitywashigher(13.9%vs9.1%,P>0.05);frequencyofseverecongestiveheartfailurewashigher(13.9%vs6.6%,P<0.02).Sothrombolyticagentshouldbestartedasearlieraspossibleaftertheonsetofacutemyocardialinfarctionifnotcontraindication....

Aclinicalstudyonthrombolysiswithintravenousurokinasein1138casesofacutemyocardialinfarctionwasreported.Inordertoinvestigatetheefectsofdiferentdosesofurokinase:1023casesofacutemyocardialinfarctiontreatedbythrombolyticagentswithin6hoursafteronsetweredividedrandomlyintotwogroups,539casesinlowdosegroup[urokinase,UK17000(22000IU)/kg,totaldosenolowerthan900000(1170000IU)]and484casesinhighdosegroup[23000U(30000IU)/kg,totaldosenomorethan1800000U(2340000IU)].Thepatencyofinfarct-re-latedcoronaryarterywasasesedbyuniformclinicalcriteria.Thepatencyrateswere67.3%and67.8%respectively(P>0.05).Four-wekmortalitywas9.5%and8.7%respectively(P>0.05).Frequencyofvariousseverecomplicationshadnostatisticalsignificancebetwenthetwogroups.Theefectsofdiferentdosesweresimilar.Adversebleedingactionswerealitlemoreinhighdosegroupthaninlowdosegroup(P>0.05).But,2casesoffatalcerebralhemorhageoccuredinthehighdosegroup.So,thelowdoseUKwasequalyefectiveandmaybesafer.(2)Efectsofdelayedthrombolytictherapy(6-12hoursafteronsetwithurokinase[20000U(26000IU)/kg]in115casesofacutemyocardialinfarctionwerestudied.Incomparisonwiththosetreatedwithin6hoursthepa-tencyrateofinfarct-relatedarterywaslower(40.0%vs67.5%,P<0.001);four-weekmortalitywashigher(13.9%vs9.1%,P>0.05);frequencyofseverecongestiveheartfailurewashigher(13.9%vs6.6%,P<0.02).Sothrombolyticagentshouldbestartedasearlieraspossibleaftertheonsetofacutemyocardialinfarctionifnotcontraindication.

为探讨急性心肌梗塞(AMI)静脉法应用国产尿激酶(UK)不同剂量的疗效和副作用,以及延迟用药的疗效。(1)对1023例发病6小时以内的AMI患者随机分为:低剂量组[1.7万U(2.2万IU)/kg]539例和高剂量组[2.3万U(3.0万IU)/kg]484例。两组血管再通率分别为67.3%和67.8%,4周病死率分别为9.5%和8.7%,各种严重并发症差异均无显著性,说明两组疗效相似,出血并发症在高剂量组略高于低剂量组,但差异无显著性。值得指出的是,在高剂量组有2例发生了致命性脑出血。认为1.7万U(2.2万IU)/kg是安全有效的剂量。(2)延迟治疗的效果,发病后6~12小时AMI患者115例[应用UK2.0万U(2.6万IU)/kg]与发病6小时内用药组相比:血管再通率低(40.0%对67.5%,P<0.001),4周病死率较高(13.9%对9.1%,但P>0.05);重度心力衰竭发生率也较高(13.0%对6.6%,P<0.02)。说明延迟治疗组疗效明显低于发病6小时内治疗者。

OBJECTIVES: To determine the efficacy and the mechanism of ramipril in treatment of congestive heart failure. METHODS:Twelve patients with severe congestive heart failure were treated with ramipril 5 mg. The hemodynamic effects were observed with a Swan-Ganz catheter over 24h.Plasma renin actlvltyandanglotensl concentration weredetermlned byradloimmunoassay.Angiotensin-converting enzyme(ACE)activity was determined by colorimetric method.RESULTS:Ramipril achived benificial hemodynamlc effects within 2h after...

OBJECTIVES: To determine the efficacy and the mechanism of ramipril in treatment of congestive heart failure. METHODS:Twelve patients with severe congestive heart failure were treated with ramipril 5 mg. The hemodynamic effects were observed with a Swan-Ganz catheter over 24h.Plasma renin actlvltyandanglotensl concentration weredetermlned byradloimmunoassay.Angiotensin-converting enzyme(ACE)activity was determined by colorimetric method.RESULTS:Ramipril achived benificial hemodynamlc effects within 2h after dosing,maximal imrovement was observed within 4h,and the beneficial hemodynamic changes lasted for 24h.Ramipril Induced a pronounced,sustained decrease in ACE activity and plasma angiotensin Ⅱ conCentration, and an increase in plasma renin activity. CONCLUTIONS: Ramipril is a potent long acting ACE inhibitor that is expected to bebeneficial in treatment of patients with cardlac failure.

目的:明确ramipril治疗心力衰竭的效应及其作用机制。方法:12名重度心力衰竭患者口服ramipril5mg,观察服药后24h血流动力学变化。放免法测定服药前后血浆肾素活力(PRA)和血管紧张素Ⅱ(AngⅡ)浓度,紫外法测定血管紧张素转化酶(ACE)活力的变化。结果:服药后2h即可见有明显的血流动力学改善,最大效应出现在服药后4h,一次服药作用可维持24h。Ramipril使ACE活力和AngⅡ浓度明显而持久地降低,PRA反应性增高。结论:Ramipril是一种作用强大的长效ACE抑制剂,可望成为治疗严重心力衰竭的安全有效药物。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关重度心力衰竭的内容
在知识搜索中查有关重度心力衰竭的内容
在数字搜索中查有关重度心力衰竭的内容
在概念知识元中查有关重度心力衰竭的内容
在学术趋势中查有关重度心力衰竭的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社